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The FDA’s Graphic Tobacco Warnings and the First
Amendment
David Orentlicher, M.D., J.D.

I

n the past, constitutional principle gave the government broad
authority to regulate tobacco or
pharmaceutical advertising. The
state’s power to safeguard the public health was strong, and companies’ freedom to plug their products was weak.
But the Supreme Court has
changed course. Whereas it once
did not view “commercial” speech
as the kind of speech the First
Amendment protects, it now gives
businesses nearly the same rights
to market their goods as it does
individuals to speak their minds.
And as the Court has broadened
corporate freedom to advertise,
it has narrowed governmental
power to preserve the public’s
health. Whereas the Court once
gave the government more leeway when invoking its interests in
public health than when asserting
other state interests, it now tends
to hold health-related rules to the
same constitutional standards as
other types of rules.1
As a result, government today
is much more susceptible to challenge when it tries to regulate
the promotional activities of the
tobacco or pharmaceutical industry. In 2011, the Supreme Court
rejected Vermont’s effort to restrict the use of prescription data
by drug companies’ sales representatives.2 And last year, the U.S.
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Court of Appeals for the D.C.
Circuit vetoed the new graphic
warnings for cigarette packages
that had been issued by the Food
and Drug Administration (FDA).3
The Supreme Court’s increasing
sympathy for corporate speech
and decreasing deference to public health authorities makes it
more difficult for government to
protect the public’s health. The
fate of the graphic cigarette warnings is illustrative.
Congress authorized the graph
ic warnings when it passed the
Family Smoking Prevention and
Tobacco Control Act in 2009.
The Act requires the use of nine
new textual warnings for cigarette packages and directs the
Department of Health and Human
Services to select color graphics
to accompany the warnings. The
images have to depict the “negative health consequences” of
smoking, with text and graphic
taking up the top halves of each
pack’s front and back panels.
In June 2011, the FDA unveiled
the nine images, including some
that were quite explicit. One
image showed a man smoking
through a tracheostomy (see image). Another showed the corpse
of a man with staples in his
chest on an autopsy table. Several tobacco companies promptly
sued, alleging that the graphic-
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warning requirements violated
their First Amendment rights.
The companies prevailed in both
the district court and the D.C.
Circuit.
In one sense, the result was
not surprising, given the Supreme
Court’s increased sympathy toward corporations and their First
Amendment rights. Regulations
of commercial speech often succumb to judicial scrutiny.
However, there was good reason to think that the D.C. Circuit
would uphold the graphic warnings. Even as the Supreme Court
has narrowed the power of government to regulate corporate
speech, it has preserved an important authority to regulate. The
graphic warnings seemed to fall
within that authority.
The preserved authority reflects the distinction the Supreme
Court makes between the regulation of corporate speech that informs and the regulation of corporate speech that misinforms.
On the one hand, the Court usually objects when the government
tries to block truthful speech by
businesses. In the prescriptiondata case, the Vermont law would
have restricted the free flow of
information about physicians’
prescribing practices. On the other hand, the Court typically approves when the government tries
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to prevent false or deceptive
speech by businesses. For example, the government may forbid
companies from saying things
that are not true. It also may require companies to make disclosures that will allow consumers
to make informed choices and
not be misled by advertising
hype. Common disclosure requirements include the corporate
prospectus for stock offerings,
the total interest payments for a
home mortgage, nutritional information for foods, and the textual warnings for cigarettes.
The graphic cigarette warnings appeared to serve purposes
similar to those of other required
disclosures. The warnings would
promote understanding of the
risks of smoking and prevent
people from being misled by
cigarette marketing.
Indeed, the U.S. Court of Appeals for the Sixth Circuit had
upheld Congress’s authority to
mandate graphic warnings.4 As
that court observed, people often do not read textual warnings
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on cigarette packages. And even
when read, the warnings may
not be effective in informing
consumers about the risks to
their health. Adding color images can ensure that textual warnings are noticed, read, and understood. Sometimes a picture really
is worth a thousand words.
Even though the Supreme Court
let the Sixth Circuit’s decision
stand, its effect is limited. The
Sixth Circuit considered only
whether Congress may require
some graphic warnings. The D.C.
Circuit considered the consti
tutionality of the FDA’s actual
warnings.
In rejecting the warnings by
a two-to-one vote, the D.C. Circuit
identified two problems. First,
the majority did not think the
images were needed to prevent
cigarette companies from misleading consumers. Other statutory provisions already prohibited
many kinds of deceptive labeling
or advertising. The court was
not willing to defer to the FDA’s
judgment that the new images
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were necessary. Second, the warnings were not designed simply to
ensure that consumers fully understand the risks to their health
from cigarettes. Instead, wrote the
majority, the warnings would primarily serve to convey the government’s antismoking message.
Indeed, each of the new images
would include the phone number for the National Cancer Institute’s tobacco cessation hotline, 1-800-QUIT-NOW. Whereas
government may use its own resources to publicize its perspectives, it generally may not force
individuals or corporations to
spend their dollars to disseminate
its viewpoint.
Rather than seek Supreme
Court review of the D.C. Circuit’s decision, the FDA opted to
return to the drawing board and
develop new graphic warnings.
In the meantime, we are left
with some important questions.
First, when do graphic warnings cross the line between trying to inform and trying to persuade? Does it depend on how
“shocking” or how prominent
they are? Two of the three D.C.
Circuit judges thought that the
images were designed to evoke
an emotional response rather than
to convey factual information.
The dissenting judge cited the
FDA’s point that warnings more
effectively communicate information when they elicit a strong
emotional reaction. In addition,
the images would provide information about risk when viewed
in conjunction with their accompanying text. For example,
the image of the man smoking
through a tracheostomy accompanied the warning “Cigarettes
are addictive” and would have illustrated the tenacity of nicotine
addiction. In the dissenter’s view,
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the images would have been acceptable without the cessation
hotline number.
Second, must the warnings
correct misleading impressions
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Whatever the answers to these
questions, companies today are
better able to promote their products, and government is less able
to promote health than was the

Whereas the Court once gave the government
more leeway when invoking its interests
in public health than when asserting other
state interests, it now tends to hold
health-related rules to the same constitutional
standards as other types of rules.
from the company’s cigarette
packaging or current advertisements, or may they also correct
misimpressions from past promotional materials?
Third, if courts will not defer
to the judgment of public health
authorities about the need for
disclosure mandates, what kind
of empirical evidence must the
FDA present in order to justify
the use of graphic warnings?

case in the past. Ironically, early
protection of commercial speech
rested in large part on the need
to serve consumers’ welfare. In
1976, for example, the Supreme
Court struck down a Virginia law
that prevented pharmacists from
advertising their prices for prescription drugs.5 The law especially hurt persons of limited
means, who were not able to shop
around and therefore might not

be able to afford their medicines.
Today, by contrast, courts are using the First Amendment to the
detriment of consumers’ welfare,
by invalidating laws that would
protect the public health.
Disclosure forms provided by the author
are available with the full text of this article at NEJM.org.
From the Hall Center for Law and Health,
Indiana University Robert H. McKinney
School of Law, and the Indiana University
School of Medicine — both in Indianapolis.
This article was published on June 26, 2013,
at NEJM.org.
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The FDA and Graphic Cigarette-Pack Warnings —
Thwarted by the Courts
Ronald Bayer, Ph.D., David Johns, B.A., and James Colgrove, Ph.D.

O

n August 24, 2012, in R.J.
Reynolds Tobacco Company v.
Food and Drug Administration, the
U.S. Court of Appeals for the
District of Columbia ruled that
the regulations proposed by the
Food and Drug Administration
(FDA) mandating the inclusion of
graphic warnings on cigarette
packs (see photo) violated the
First Amendment: they would
compel companies to express
antitobacco messages on their
own dime. Seven months later,
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on March 14, 2013, the Department of Justice announced that
the government would not appeal
that decision to the Supreme
Court.
In explaining the decision not
to defend the regulations, which
had been developed pursuant to
congressional mandate under the
2009 Family Smoking Prevention
and Tobacco Control Act, Attorney
General Eric Holder stated that
the FDA would “undertake research to support a new rulemak-
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ing consistent with the Tobacco
Control Act.” If new graphic
warnings that emerged from the
process were also deemed unconstitutional, “there will be an opportunity to seek full Supreme
Court review at that time.”1 Howard Koh, Assistant Secretary for
Health, described the setback in
cautious language: “Although we
pushed forcefully for graphic
health warning labels to appear
on cigarette packages, the D.C.
Circuit’s ruling against the warn-
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